To identify critical amino acid residues recognized by alloreactive cytolytic T lymphocytes (CTL) generated between H-2Kb and H-2Kb^l, we have derived a series of cloned L-cell lines expressing the following mutant H-2Kb class I genes. Cell line L-KbTYr-TYr expresses a mutant gene in which positions 155-156 of the Kb molecule have been changed from Arg-Leu to Tyr-Tyr, leaving position 152 unchanged. Cell line L-KbA' expresses the reciprocal mutant gene that has position 152 of the Kb molecule mutated from glutamic acid to alanine, leaving positions 155-156 unchanged. Electrophoretic mobilities of the mutant Kb molecules reflect only those changes predicted by the mutations. Mutant-specific (anti-KbIi) and nativespecific (anti-Kb) CTL lyse L-KbTYr-Tyr and L KbAa target cells equally well. Unlabeled target inhibition of lysis revealed a pattern ofrecognition and inhibition that suggests that the amino acid differences between Kblu and Kb create at least two discrete determinants that can be recognized by different populations of CTL. The results suggest that these determinants consist, at least in part, of a linear amino acid sequence from which critical amino acid residues can be identified.
The class I genes of the murine major histocompatibility complex (H-2) encode the serologically defined transplantation antigens that serve as major recognition elements in cytolytic T-lymphocyte (CTL) responses to foreign antigens (1) . Class I antigens are Mr 45,000 integral membrane glycoproteins that exhibit three extracellular domains, al, a2, and a3, a transmembrane region, and a short cytoplasmic tail. Alloreactive CTL recognize non-self class I antigens directly, whereas H-2-restricted CTL recognize self-class I structures in association with a nominal foreign antigen-e.g., viral, tumor, or chemical (2) . Several approaches have been used to localize the precise regions and determinants on class I molecules involved in CTL recognition (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) . These studies all clearly indicate that the extracellular a, and a2 domains of class I molecules express the predominant determinants recognized by CTL, whereas the a3, transmembrane, and cytoplasmic domains appear to be uninvolved. Sequence analysis has shown that as few as one or two amino acid substitutions in either of the a1 or a2 domains are sufficient to alter CTL recognition (6, 16) . Although a pattern of crossreactive allorecognition can be determined for different class I mutants that correlates with common elements of primary amino acid sequence, the majority of CTL appear to recognize determinants that are dependent on domain interactions. Therefore, although the location of the determinants has been effectively "domain mapped," the relationship between linear sequence and determinant formation remains unknown.
Studies involving in vitro-and in vivo-derived mutations of class I genes provide model systems for establishing the minimal biochemical requirements necessary to effect CTL recognition. However, in vivo-derived spontaneous mutations are limited in number, and those that exhibit unique noncrossreactive determinants, such as the Kbm' mutation, express multiple amino acid substitutions that complicate critical residue identification. In vitro-derived mutations are equally limited in that they are generated randomly and are negatively selected on the basis of the lack of expression of either serological or CTL-specific epitopes. It is possible to avoid these limitations by using site-directed mutagenesis to alter the sequence of a well-characterized class I mutation that displays significant functional changes in recognition such that critical residues can be identified. This is the rationale and the approach that we have taken to study the Kbml mutation. The Kbml gene differs from the native Kb gene by a cluster of seven nucleotides that result in three amino acid substitutions (position 152, glutamic acid -alanine; positions 155-156, Arg-Leu --Tyr-Tyr) (17) (18) (19) (20) . These substitutions are sufficient to elicit bidirectional graft rejection in vivo and mixed lymphocyte responses in vitro between the parent C57BL/6 and mutant B6.C-H-2bml mouse strains (16, 21 (22) (23) (24) (25) .
We have generated two mutant Kb genes by oligonucleotide-directed mutagenesis. When tTo whom reprint requests should be addressed.
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Oligonucleotide-Directed Mutagenesis. Oligonucleotides were synthesized on a Systec Microsyn 1450 automated DNA synthesizer and purified by HPLC according to published procedures (26) . Oligonucleotide-directed mutagenesis was carried out as described (27, 28) . The sequences of the various genes and their expressed products are shown in Table 1 .
Generation and Identification of Transfected L-Cell Lines. Mouse L cells deficient in thymidine kinase were cotransformed with the ptK5 plasmid and a plasmid vector containing one of the four different class I genes by using a standard calcium phosphate precipitation method (29) ; this was followed by selection in hypoxanthine/aminopterin/thymidine medium. Surviving colonies were cloned and assayed for expression of H-2Kb-like class I products by radioimmunoassay (RIA) according to published procedures (5) Isolation of Class I Molecules. The procedures for radiolabeling, immunoprecipitation, isolation of proteins, and twodimensional (2D) gels have been described (33, 34) .
Generation and Analysis of CTL Specificities. Alloreactive CTL were generated in vitro according to published procedures (35) . H-2Kbml-specific CTL were generated by using C57BL/6 responder cells with B6.C-H-2bml stimulator cells. Likewise, H-2Kb-specific CTL were generated by using B6.C-H-2bml responder cells and C57BL/6 stimulator cells. Specific cell lysis was measured by a standard 51Cr-release assay (35) . Percent specific lysis was calculated as (cpm experimental -cpm spontaneous/cpm maximal -cpm spontaneous) x 100. Specific cell lysis of labeled targets in the presence of various unlabeled targets was carried out by the 51Cr-release assay above. Percent inhibition was calculated as (1 -% specific lysis in the presence of unlabeled targets/% specific lysis in the absence of unlabeled target) x 100. RESULTS 2D Gel Electrophoresis. The mutant molecules were isolated by immunoprecipitation of biosynthetically radiolabeled cell lysates and analyzed the resulting immune complexes by 2D gel electrophoresis.
Complete and partial fluorographs of the 2D gels of the transfectants are shown in Fig. 1 . Fig. 1 A and 
3. Plasmids pC15-1, pA43, and R6E2 have been identified and characterized (28) . 1D , the analogous spot falls to the left (more basic) of this line, whereas in Fig. 1E the reverse is true-the most basic spot is to the right (more acidic). This is to be expected since the KbAla molecule (Fig. 1D) or H-2Kbm1 molecules. As shown in Fig. 2 , H-2Kb-specific (Fig. 2B ) and H-2Kbm1_specific ( Fig. 2A) CTL are able to lyse each of the mutant targets L-KbTYrTYr and L-KbA'a equally well while maintaining exquisite specificity for the stimulating population ( Fig. 2A, Kbml; Fig. 2B, Kb) . However, the level of killing on each mutant cell line was less than that observed for the cell lines expressing native Kb (L-Kb) or the whole mutant Kbbml (L-Kbml) antigens. Since the RIA data indicate that similar amounts of surface protein are present on each of the cell lines, this suggests that the reduced level of killing is unlikely to be caused by differences in the number of surface molecules but rather reflects the ability of the CTL population to recognize the unique determinants presented by the Kb mutant molecules KbTYr-TYr and KbAla. Fig. 2C shows the ability of each of the cell lines to be lysed by H-2k-specific CTL. The level of lysis on each cell line appears to correlate with the level of expression of H-2 antigens determined by RIA with antibody 16-1-2.
1-2Kb-and H-2Kbm'-Specific CTL Recognize Different
Determinants on KbTlTYr and KbAw Antigens. Since each population of CTL recognizes both mutants equally well, unlabeled target inhibition of lysis was performed to determine whether common or independent determinants are being recognized on the KbTYr-TYr and KbAla mutant structures. Fig. 3 Upper and Lower clearly show that although L-KbTr-TYr and L-KbAla are able to inhibit lysis of themselves, L-KbTYrTYr is not able to inhibit the lysis of L-KbAIa targets, or vice versa, regardless of the specificity of the CTL population. We therefore conclude that the determinants recognized by each population of CTL are discrete and independent.
Line L-KbTYr-TYr is able to partially inhibit the lysis of L-Kbml by anti-Kbml-specific CTL as well as partially inhibit the killing of L-K" targets by anti-Kb-specific CTL. Likewise, L-KbAla cells are able to partially inhibit the killing of L-Kbm1l targets by anti-Kbml-specific CTL as well as partially inhibit the lysis of L-K" targets by anti-K -specific CTL. L-Kb and L-Kbml targets also show partial inhibition on L-KbTYr-TYr and L-KbAla when the CTL population has specificity for the inhibitor. These data suggest that the determinant(s) recognized on the mutant structures KbTYr-TYr and KbAla is also present on the native Kb and Kbbml structures. These observations are consistent with the idea that the amino acid differences between Kb and Kbml create multiple determinants that can be recognized by different subpopulations of CTL with different specificities.
DISCUSSION
In direct lysis experiments B6 anti-bml CTL (anti-Kbml), which are generated specifically as a result of the three amino acid substitutions (position 152, glutamic acid -+ alanine; positions 155-156, Arg-Leu -* Tyr-Tyr), are able to recognize each of the partial mutations KbTYrTYr (glutamic acid, Tyr-Tyr) and KbAla (alanine, Arg-Leu) equally well while maintaining specificity for the stimulator population, Kbml.
If anti-Kbml-specific CTL recognize conformational determinants revealed as a consequence of the three amino acid substitutions in Kbml, then it could be argued that the double Tyr-Tyr mutation, KbTYrTYr, is sufficient to induce similar steric effects on the a2 structure, resulting in the recognition of L-KbTYr-TYr targets by Kbml-specific CTL. It has been noted that the presence of a similar primary amino acid sequence among different Kb mutants correlates with their ability to be recognized by alloimmune CTL (6) . A similar, well. This implies that conformational changes induced by the double Tyr-Tyr mutation (or the single alanine substitution) are sufficient to permit recognition by anti-Kbml_ specific CTL but not sufficient to destroy the recognition by anti-Kb-specific CTL that does occur when the triple mutation (alanine, Tyr-Tyr) is present. In other words, conformational determinants that are gained as a result of the triple mutation (Kbml specific) and those that are lost as a result of the same mutation (Kb specific) are simultaneously maintained and generated when either a single alanine substitution or a double Tyr-Tyr substitution is made. There are no indications of any significant structural changes induced in the Kb mutant molecules as assessed by their ability to bind the Kb/Kbml antibody 20-8-4 (RIA and immunoprecipitation). Likewise, changes in local and extended helical structure and hydrophilicity based on Robson (36) and HoppWoods (37) predictions, respectively, are minimal (data not shown).
We propose that anti-Kb-and anti-K"'-specific CTL (38) .
The recent description by Bjorkman et al. (39, 40) of the x-ray crystallographic structure of a human class I antigen has provided the basis for a general model ofclass I structure. (43, 44) , it has been suggested that the phenomenon ofclass I alloreactivity is also mediated by CTL recognition of peptide fragments (45, 46 
